BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.6.1//EN
X-ORIGINAL-URL:https://vanguard-project.eu/
X-WR-CALNAME:VANGUARD
X-WR-CALDESC:New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-88a839f2f6f1427879fc33ee4acf4f66@vanguard-project.eu
DTSTART:20241126T183000Z
DTEND:20241126T193000Z
DTSTAMP:20241029T092300Z
CREATED:20241029
LAST-MODIFIED:20241029
PRIORITY:5
SEQUENCE:10
TRANSP:OPAQUE
SUMMARY:Current Developments in Cell Therapy: Stem Cells, Porcine Islet Cells, and Bioartificial Pancreas in the VANGUARD Project
DESCRIPTION:Date: 26 November 2024, 19:30\nLocation: Lecture Hall, Medizinische Klinik und Poliklinik IV, LMU Klinikum Innenstadt, Ziemssenstr. 5, 80336 Munich\nWe are pleased to announce that this presentation will be led by Prof. Dr. med. Jochen Seißler, Head of Diabetology, Medizinische Klinik – Innenstadt, LMU Munich, and partner in the VANGUARD Project. Prof. Dr. Seißler will provide insights into the latest advancements in cell therapy for type 1 diabetes, covering developments in stem cell therapy, porcine islet cells, and bioartificial pancreas technology.\nEvent Details:\n\nLanguage: German\nTarget Audience: This event is aimed at type 1 diabetes patients and diabetes peer support groups, including the Munich Insulin Pump Support Group.\nOpen to the Public: Yes\n\nFor further details, please visit www.shg-insulinpumpentraeger.de/veranstaltungen/\n
URL:https://vanguard-project.eu/events/current-developments-in-cell-therapy-stem-cells-porcine-islet-cells-and-bioartificial-pancreas-in-the-vanguard-project/
ATTACH;FMTTYPE=image/jpeg:https://vanguard-project.eu/wp-content/uploads/sites/23/2024/10/updates-in-therapies.jpg
END:VEVENT
END:VCALENDAR